The Highest Standard in Peptide Research.

Bodytide Wellness Lab
WEIGHT MANAGEMENT & METABOLIC OPTIMISATION

GLP3 30MG

An Intelligent Approach weight loss and appetite control

GLP-3 is an investigational triple-hormone agonist designed to evaluate accelerated fat oxidation and appetite regulation.

GLP3 30MG
£159.00

Active Ingredient: 30.00mg per pen

Volume: 3.00ml

For in vitro use only.

Typical research suggests 5 clicks daily, weeks 1-2. Then 10 clicks daily thereafter.

All our Peptide Pens are designed to last a minimum of 30 days.

Taxes included. Shipping calculated at checkout.

Expected Benefits

By combining clinical research with day-to-day wellness support, this protocol offers clear metabolic improvements:

Accelerated Fat Loss: Promotes direct lipid clearance and the breakdown of deep adipose tissue.
Appetite Regulation: Calms persistent hunger signals in the brain to support dietary compliance.
Consistent Energy: Optimises cellular energy usage, preventing physical fatigue associated with caloric deficits.
Blood Sugar Stability: Restores balance to glucose pathways, preventing insulin spikes and crashes.
Systemic Markers: Supports positive, documented changes in waist circumference and cholesterol levels.

Manufactured and tested to
pharmaceutical standards

EU GMP ISO 9001 ISO 13485 ISO 14644
To maintain the integrity of your protocol, correct storage is essential. Always store your Peptide pen in its protective casing within the refrigerator, strictly between 2°C and 8°C. Ensure the pen is shielded from direct light and never allowed to freeze. When travelling, we recommend utilizing a temperature-controlled travel case.

What is GLP3 30MG?

GLP-3 is a synthetic peptide engineered to target three distinct hormone pathways simultaneously. Unlike single-receptor options, it communicates with biological systems to regulate appetite, stabilise blood sugar, and optimise cellular energy usage. It represents a streamlined, highly precise approach to weight management and biological longevity, designed for clear, measurable research outcomes.

The Cellular Mechanism

GLP-1 (Glucagon-Like Peptide-1): Signals satiety to the brain and slows gastric emptying to maintain fullness.
GIP (Glucose-Dependent Insulinotropic Polypeptide): Improves how the body utilizes insulin and processes blood glucose.
Glucagon: Upregulates liver fat oxidation and metabolism to accelerate calorie and fat clearance.

Protocol Schedule

Clinical evaluation studies show that a typical research protocol ranges from 2.5mg to 5mg weekly. To ensure a smooth transition and allow cellular receptors to adapt comfortably, researchers follow a step-by-step escalation schedule:

Weeks 1–2 (Baseline Priming): An initial low introductory dose of 2.5mg once per week (25 clicks once per week).

Weeks 2 Onwards (Active Titration): The protocol scales to an intermediate level of 5mg twice per week (25 clicks twice per week).

Once target weight loss is achieved, dosage can be reviewed again.

Possible Side Effects

Digestive Shift: Mild, temporary nausea, indigestion, or changes in bowel habits as the system adapts to slower gastric emptying.
Satiety Pressure: A pronounced sensation of fullness or minor reflux.
Site Sensitivity: Minor, transient redness or warmth at the application site.